P. Maton

发表

Profile and assessment of GERD pharmacotherapy.

P. Maton, 2003, Cleveland Clinic journal of medicine.

Safety and Efficacy of Long Term Esomeprazole Therapy in Patients with Healed Erosive Oesophagitis

P. Lundborg, N. Vakil, C. Hwang, 2001, Drug safety.

Meal Type Affects Heartburn Severity

M. Robinson, P. Miner, P. Maton, 1998, Digestive Diseases and Sciences.

Omeprazole is superior to ranitidine plus metoclopramide in the short‐term treatment of erosive oesophagitis

A. McCullough, S. Sabesin, V. Rustgi, 1993, Alimentary pharmacology & therapeutics.

Effect of a long-acting somatostatin analogue (SMS 201-995) in a patient with pancreatic cholera.

R. Jensen, J. Gardner, J. Howard, 1985, The New England journal of medicine.

Recent advances in the management of gastric acid hypersecretion in patients with Zollinger-Ellison syndrome.

R. Jensen, J. Gardner, P. Maton, 1989, Gastroenterology clinics of North America.

Efficacy of omeprazole versus ranitidine for symptomatic treatment of poorly responsive acid reflux disease—a prospective, controlled trial

P. Maton, B. Joelsson, R. Orlando, 1999, Alimentary pharmacology & therapeutics.

Somatostatin and Somatostatin Analogue (SMS 201-995) in Treatment of Hormone-Secreting Tumors of the Pituitary and Gastrointestinal Tract and Non-Neoplastic Diseases of the Gut

V. Go, P. Gorden, P. Maton, 1989 .

Use of long-acting somatostatin analog SMS 201-995 in patients with pancreatic islet cell tumors

R. Jensen, J. Gardner, P. Maton, 1989, Digestive Diseases and Sciences.

Effects of curative gastrinoma resection on gastric secretory function and antisecretory drug requirement in the Zollinger-Ellison syndrome.

D. Metz, J. Norton, R. Jensen, 1992, Gastroenterology.

Pathophysiological effects of long-term acid suppression in man

R. Riddell, P. Sipponen, A. Walan, 1995, Digestive Diseases and Sciences.

Gastrinomas: comparison of MR imaging with CT, angiography, and US.

J. Norton, J. Doppman, D. Miller, 1989, Radiology.

Aggressive Resection of Metastatic Disease in Selected Patients with Malignant Gastrinoma

J. Norton, J. Doppman, R. Jensen, 1986, Annals of surgery.

Intraoperative Ultrasonographic Localization of Islet Cell Tumors: A Prospective Comparison to Palpation

J. Norton, T. Shawker, J. Doppman, 1988, Annals of surgery.

Interaction of Calcitonin Gene‐Related Peptides with Pancreatic Acinar Cells and Dispersed Gastric Smooth Muscle Cells

R. Jensen, P. Maton, Z. Zhou, 1992, Annals of the New York Academy of Sciences.

High-performance liquid chromatography of gastrointestinal hormones.

C. Selden, P. Maton, V. Chadwick, 1988, Monographs on endocrinology.

Reversed-phase high-performance liquid chromatography and separation of peptide hormones in human tissues and plasma with reference to cholecystokinins.

C. Selden, P. Maton, V. Chadwick, 1984, Journal of chromatography.

3 Carcinoid and neuroendocrine tumours of the liver

P. Maton, H. Hodgson, 1987 .

Gallbladder contraction: hormonal regulation

P. Maton, V. Chadwick, A. Selden, 1983 .

Expanding uses of octreotide.

P. Maton, 1994, Bailliere's clinical gastroenterology.

The carcinoid syndrome.

P. Maton, 1988, JAMA.

URSODEOXYCHOLIC ACID TREATMENT OF GALLSTONES Dose-response Study and Possible Mechanism of Action

R. Dowling, G. Murphy, P. Maton, 1977, The Lancet.

Therapeutic Use of Somatostatin and Octreotide Acetate in Neuroendocrine Tumors

R. Arakaki, P. Maton, 1992 .

Hepatic HMGCoA reductase in human cholelithiasis: effects of chenodeoxycholic and ursodeoxycholic acids*

H. Ellis, M. Higgins, P. Maton, 1980, European journal of clinical investigation.

Cushing's syndrome in patients with the Zollinger-Ellison syndrome.

R. Jensen, J. Gardner, P. Maton, 1986, The New England journal of medicine.

Activities of calcitonin gene-related peptide (CGRP) and related peptides at the CGRP receptor

R. Jensen, J. Gardner, P. Maton, 1990, Peptides.

Successful Therapy of Pancreatic Cholera with the Long-Acting Somatostatin Analogue SMS 201-995: Relation between Plasma Concentrations of Drug and Clinical and Biochemical Responses

R. Jensen, W. Malarkey, J. Gardner, 1986 .

Intravenous omeprazole in patients with Zollinger-Ellison syndrome undergoing surgery.

J. Norton, R. Jensen, J. Gardner, 1990, Gastroenterology.

Secretin and calcium provocative tests in the Zollinger-Ellison syndrome. A prospective study.

R. Jensen, S. Wank, J. Gardner, 1989, Annals of internal medicine.

The effect of Zollinger-Ellison syndrome and omeprazole therapy on gastric oxyntic endocrine cells.

R. Jensen, J. Gardner, P. Maton, 1990, Gastroenterology.

Zollinger-Ellison Syndrome

P. Maton, 1996, Drugs.

Multiple hormone elevations in Zollinger-Ellison syndrome: Prospective study of clinical significance and of the development of a second symptomatic pancreatic endocrine tumor syndrome

R. Jensen, J. Gardner, P. Maton, 1990 .

Multiple hormone elevations in Zollinger-Ellison syndrome. Prospective study of clinical significance and of the development of a second symptomatic pancreatic endocrine tumor syndrome.

R. Jensen, J. Gardner, P. Maton, 1990, Gastroenterology.

Gastrinomas: localization by means of selective intraarterial injection of secretin.

J. Norton, J. Doppman, D. Miller, 1990, Radiology.

Medical management of patients with Zollinger-Ellison syndrome who have had previous gastric surgery: a prospective study.

R. Jensen, S. Wank, J. Gardner, 1988, Gastroenterology.

Effect of parathyroidectomy in patients with hyperparathyroidism, Zollinger-Ellison syndrome, and multiple endocrine neoplasia type I: a prospective study.

J. Norton, J. Doppman, R. Jensen, 1987, Surgery.

Prospective Study of Gastrinoma Localization and Resection in Patients with Zollinger‐Ellison Syndrome

J. Norton, J. Doppman, R. Jensen, 1986, Annals of surgery.

Relationship between hepatic cholesterol synthesis and biliary cholesterol secretion in man: hepatic cholesterol synthesis is not a major regulator of biliary lipid secretion.

R. Dowling, P. Maton, A. Reuben, 1982, Clinical science.

Defective gallbladder emptying and cholecystokinin release in celiac disease. Reversal by gluten-free diet.

P. Maton, V. Chadwick, A. Selden, 1985, Gastroenterology.

Antacids Revisited

M. Burton, P. Maton, 1999, Drugs.

Prospective study of the standard meal provocative test in Zollinger-Ellison syndrome.

R. Jensen, J. Gardner, H. A. Stark, 1989, The American journal of medicine.

Use of octreotide acetate for control of symptoms in patients with islet cell tumors

P. Maton, 1993, World journal of surgery.

Recent Advances in the Management of Islet Cell Tumors

P. Maton, 1989 .

Neutral endopeptidase (EC 3.4.24.11) modulates the contractile effects of neuropeptides on muscle cells from the guinea‐pig stomach

N. Bunnett, N. Bunnett, P. Maton, 1993, Experimental physiology.

Outcome of Chenodeoxycholic Acid (CDCA) Treatment in 125 Patients with Radiolucent Gallstones: FACTORS INFLUENCING EFFICACY, WITHDRAWAL, SYMPTOMS AND SIDE EFFECTS AND POST‐DISSOLUTION RECURRENCE

R. Dowling, G. Murphy, P. Maton, 1982, Medicine.

Oral and intravenous dosage forms of pantoprazole are equivalent in their ability to suppress gastric acid secretion in patients with gastroesophageal reflux disease

D. Metz, J. Pisegna, J. Paul, 2000, American Journal of Gastroenterology.

Famotidine, a new, potent, long-acting histamine H2-receptor antagonist: comparison with cimetidine and ranitidine in the treatment of Zollinger-Ellison syndrome.

R. Jensen, J. Gardner, J. Howard, 1985, Gastroenterology.

Large and small forms of cholecystokinin in human plasma: measurement using high pressure liquid chromatography and radioimmunoassay

P. Maton, V. Chadwick, A. Selden, 1982, Regulatory Peptides.

Benzodiazepine analogues L365,260 and L364,718 as gastrin and pancreatic CCK receptor antagonists.

R. Jensen, S. Wank, J. Gardner, 1989, The American journal of physiology.

Characterization of opioid receptors on smooth muscle cells from guinea pig stomach.

R. Jensen, L. Zhang, P. Maton, 1992, American Journal of Physiology.

Salivary and gastric epidermal growth factor in patients with Zollinger-Ellison syndrome: its protective potential

R. Jensen, R. McCallum, J. Pisegna, 2000, American Journal of Gastroenterology.

Multiple endocrine neoplasia type II with Zollinger-Ellison syndrome caused by a solitary pancreatic gastrinoma.

J. Norton, J. Doppman, R. Jensen, 1989, JAMA.

Zollinger-Ellison Syndrome and Other Acid-Hypersecretory States

P. Maton, 2001 .

The management of Zollinger—Ellison syndrome

P. Maton, 1993, The Gastroenterologist.

Effects of oral rabeprazole on oesophageal and gastric pH in patients with gastro‐oesophageal reflux disease

T. Humphries, M. Robinson, P. Maton, 1997, Alimentary pharmacology & therapeutics.

Oral and intravenous dosage forms of pantoprazole are equivalent in their ability to suppress gastric acid secretion in patients with gastroesophageal reflux disease.

D. Metz, J. Pisegna, J. Paul, 2000 .

Prospective study of chemotherapy in patients with metastatic gastrinoma.

J. Norton, J. Doppman, S. Wank, 1988, Gastroenterology.

Safety and efficacy of long-term treatment with esomeprazole in patients with healed erosive esophagitis (EE)

N. Vakil, C. Hwang, B. Hamelin, 2000 .

Selective venous sampling for gastrin to localize gastrinomas. A prospective assessment.

J. Norton, J. Doppman, D. Miller, 1986, Annals of internal medicine.

Omeprazole: effective, convenient therapy for Zollinger-Ellison syndrome.

R. Jensen, J. Gardner, J. Howard, 1985, Gastroenterology.

Current Management of Zollinger-Ellison Syndrome

R. Jensen, J. Gardner, P. Maton, 1986, Drugs.

The ability of operative endoscopic transillumina- Detection of Duodenal Gastrinomas by

J. Norton, J. Doppman, R. Jensen, 1999 .

Role of acid suppressants in patients with Zollinger–Ellison Syndrome

P. Maton, 1991, Alimentary pharmacology & therapeutics.

Detection of duodenal gastrinomas by operative endoscopic transillumination. A prospective study.

J. Norton, J. Doppman, R. Jensen, 1990, Gastroenterology.

Zollinger-Ellison Syndrome in the Intensive Care Setting

J. Doppman, R. Jensen, J. Gardner, 1989 .

Long-term efficacy and safety of omeprazole in patients with Zollinger-Ellison syndrome: a prospective study.

R. Jensen, J. Gardner, H. Frucht, 1989, Gastroenterology.

Bone metastases in malignant gastrinoma.

R. Jensen, J. Barton, B. Hirschowitz, 1986, Gastroenterology.

Famotidine in the therapy of gastric hypersecretory states.

R. Jensen, S. Wank, J. Gardner, 1986, The American journal of medicine.

Properties of receptors for gastrin and CCK on gastric smooth muscle cells.

R. Jensen, J. Gardner, P. Maton, 1989, The American journal of physiology.

Reflux esophagitis in patients with Zollinger-Ellison syndrome.

R. Jensen, J. Gardner, H. Frucht, 1990, Gastroenterology.

Famotidine: effective treatment of Zollinger-Ellison syndrome.

R. Jensen, S. Wank, J. Gardner, 1987, Journal of clinical gastroenterology.

A primary role for protein kinase A in smooth muscle relaxation induced by adrenergic agonists and neuropeptides.

R. Jensen, P. Maton, Z. Gu, 1992, The American journal of physiology.

Peptic ulcer perforation as the presentation of Zollinger-Ellison syndrome

R. Jensen, J. Gardner, I. Waxman, 2005, Digestive Diseases and Sciences.

Therapeutic use of omeprazole in man : pharmacology, efficacy, toxicity, and comparison with H2 receptor antagonists

G. Sachs, P. Maton, B. Wallmark, 1991 .

Prospective study of efficacy and safety of lansoprazole in Zollinger-Ellison syndrome

D. Metz, R. Jensen, J. Pisegna, 1993, Digestive Diseases and Sciences.

Use of omeprazole in patients with Zollinger-Ellison syndrome

R. Jensen, H. Frucht, P. Maton, 1991, Digestive Diseases and Sciences.

Prospective study of the ability of computed axial tomography to localize gastrinomas in patients with Zollinger-Ellison syndrome.

J. Norton, J. Doppman, D. Miller, 1987, Gastroenterology.

Role of hepatic arterial embolisation in the carcinoid syndrome.

M. Camilleri, D. Allison, G. Griffin, 1983, British medical journal.

Resistance to chenodeoxycholic acid (CDCA) treatment in obese patients with gall stones*

R. Dowling, G. Murphy, P. Maton, 1978, British medical journal.

Characterization of receptors for calcitonin gene-related peptide on gastric smooth muscle cells.

R. Jensen, S. Collins, J. Gardner, 1988, The American journal of physiology.

Pancreatic exocrine and endocrine responses in chronic pancreatitis.

T. Adrian, S. Bloom, T. Cox, 1984, The American journal of gastroenterology.

Allelic loss on chromosome 11 in hereditary and sporadic tumors related to familial multiple endocrine neoplasia type 1.

J. Norton, E. Friedman, E. Oldfield, 1991, Cancer research.

The Impact of Gastroesophageal Reflux Disease on Health-related Quality of Life 1 1 Supported by res

D. Revicki, M. Wood, P. Maton, 1998 .

Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: a randomized controlled trial

P. Kahrilas, J. Richter, J. Johanson, 2001, American Journal of Gastroenterology.

"Downhill" esophageal varices and occlusion of superior and inferior vena cavas due to a systemic venulitis.

D. Allison, P. Maton, V. Chadwick, 1985, Journal of clinical gastroenterology.

Baillière’s Clinical Gastroenterology

P. Maton, 1997 .

Pharmacology of the Parietal Cell

P. Maton, B. Wallmark, G. Sachs, 1991 .

Retrospective comparison of 'Cheno' and 'Urso' in the medical treatment of gallstones.

R. Dowling, G. Murphy, P. Maton, 1982, Gut.

Somatostatin receptor subtype 3 mediates the inhibitory action of somatostatin on gastric smooth muscle cells.

D. Coy, V. Corleto, S. Mantey, 1995, The American journal of physiology.

D. Revicki, P. Maton, R. Orlando, 1998, Digestive Diseases.

Management of islet cell tumors in patients with multiple endocrine neoplasia: a prospective study.

J. Norton, J. Doppman, R. Jensen, 1989, Surgery.

Healing Marginal Ulcers in Patients Who Have Had a Roux-en-Y Gastric Bypass.

P. Maton, 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

The use of the long-acting somatostatin analogue, octreotide acetate, in patients with islet cell tumors.

P. Maton, 1989, Gastroenterology clinics of North America.

Zollinger-Ellison syndrome: technique, results, and complications of portal venous sampling.

D. Metz, J. Norton, J. Doppman, 1992, Radiology.

The use of high-resolution intraoperative ultrasound to localize gastrinomas: An initial report of a prospective study

J. Norton, T. Shawker, J. Doppman, 1987, World Journal of Surgery.

Review article: the management of Zollinger-Ellison syndrome.

P. Maton, 1993, Alimentary pharmacology & therapeutics.

CLINICAL MEASUREMENT OF SERUM C‐REACTIVE PROTEIN IN THE MONITORING AND DIFFERENTIAL DIAGNOSIS OF INFLAMMATORY DISEASES AND TISSUE NECROSIS AND IN THE RECOGNITION AND MANAGEMENT OF INTERCURRENT INFECTION

A. Maseri, G. Hughes, D. Catovsky, 1982 .

Comparison of the effectiveness of ranitidine and cimetidine in inhibiting acid secretion in patients with gastric hypersecretory states.

R. Jensen, J. Gardner, J. Howard, 1984, The American journal of medicine.

Antacids revisited: a review of their clinical pharmacology and recommended therapeutic use.

M. Burton, P. Maton, 1999, Drugs.

Parenteral antisecretory drug therapy in patients with Zollinger-Ellison syndrome.

J. Norton, R. Jensen, J. Gardner, 1989, Gastroenterology.

Role of selective angiography in the management of patients with Zollinger-Ellison syndrome.

J. Norton, J. Doppman, D. Miller, 1987, Gastroenterology.

Sham feeding and pancreatic secretion. Evidence for direct vagal stimulation of enzyme output.

P. Maton, V. Chadwick, A. Anagnostides, 1984, Gastroenterology.

Ovarian Carcinoma as a Cause of Zollinger-Ellison Syndrome Natural History, Secretory Products, and Response to Provocative Tests

J. Norton, R. Jensen, S. Mackem, 1989 .

C-terminal peptides of calcitonin gene-related peptide act as agonists at the cholecystokinin receptor

S. Moore, P. Maton, T. Pradhan, 1990, Peptides.

Stereologic investigations of human gastric mucosa. II. Oxyntic mucosa from patients with Zollinger-Ellison syndrome.

R. Jensen, J. Gardner, K. Helander, 1992, Scandinavian journal of gastroenterology.

Treating ulcers and reflux: what's new?

R. McCallum, D. McCarthy, P. Maton, 1992 .

Bile lipid secretion in obese and non-obese individuals with and without gallstones.

R. Dowling, G. Murphy, P. Maton, 1985, Clinical science.

An evaluation of human recombinant α interferon in patients with metastatic gastrinoma

D. Metz, J. Norton, J. Doppman, 1993 .

CIRCULATING CHOLECYSTOKININ (CCK) IS NOT THE ONLY MEDIATOR OF POSTPRANDIAL GALLBLADDER EMPTYING

P. Maton, V. Chadwick, A. Selden, 1984 .

Carbobenzoxy amino acids: structural requirements for cholecystokinin receptor antagonist activity.

R. Jensen, J. Gardner, P. Maton, 1985, The American journal of physiology.

Comment on the paper by Waldum et al. Risks of hypergastrinemia.

P. Maton, 1995, Digestive Diseases.

Helicobacter pylori and Zollinger-Ellison syndrome

D. Graham, R. Jensen, P. Maton, 2005, Digestive Diseases and Sciences.

EFFECTS OF ALUMINUM/MAGNESIUM HYDROXIDE AND CALCIUM CARBONATE ON ESOPHAGEAL AND GASTRIC pH IN SUBJECTS WITH HEARTBURN

M. Robinson, P. Maton, D. Decktor, 1995, American journal of therapeutics.

Cholecystokinin Antagonists

R. Jensen, J. Gardner, P. Maton, 1986, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Pharmacokinetics of oral and intravenous omeprazole in patients with the Zollinger-Ellison syndrome.

R. Jensen, J. Gardner, H. Frucht, 1991, Gastroenterology.

Zollinger-Ellison syndrome. Recent advances in the management of the gastrinoma.

R. Jensen, J. Gardner, H. Frucht, 1990, Gastroenterology clinics of North America.

A prospective study of perioperative and postoperative control of acid hypersecretion in patients with Zollinger-Ellison syndrome undergoing gastrinoma resection.

J. Norton, D. Fraker, R. Jensen, 1988, Surgery.

The utility of circulating levels of human pancreatic polypeptide as a marker for islet cell tumors.

H. Langstein, J. Norton, R. Jensen, 1990, Surgery.

Lack of response to chenodeoxycholic acid in obese and non-obese patients. Role of cholesterol synthesis and possible response to ursodeoxycholic acid.

R. Dowling, G. Murphy, P. Maton, 1980, Gut.

Ursodeoxycholic Acid (UDCA) Therapy of Gallstones. is Correction of Biliary Cholesterol Saturation Index According to Percentage UDCA in Bile Necessary for Prediction of Gallstone Dissolution

R. Dowling, P. Maton, N. Tanida, 1979 .

Omeprazole: An Effective Drug for Zollinger-Ellison Syndrome

R. Jensen, J. Gardner, J. Howard, 1986 .

Inhibition of peptidases potentiates enkephalin-stimulated contraction of gastric muscle cells.

N. Bunnett, P. Maton, D. Menozzi, 1991, The American journal of physiology.

Irritable bowel syndrome: a study to investigate the mechanism(s) of visceral hypersensitivity.

P. Maton, S. Rodriguez, B. Greenwood, 1996, The Journal of the Oklahoma State Medical Association.

Zollinger-Ellison Syndrome

P. Maton, 1996, Drugs.

Infusion of cholecystokinin octapeptide in man: relation between plasma cholecystokinin concentrations and gallbladder emptying rates

P. Maton, V. Chadwick, A. Selden, 1984, European journal of clinical investigation.

The carcinoid syndrome.

P. Maton, 1988, JAMA.